Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring

Muscle Relaxation With Biofeedback Via Internet for Panic disorder-a Randomized Pilot Study

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01671033

Enrollment

Registered

2012-08-23

Start date

2010-02-28

Completion date

2011-01-31

Last updated

2012-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Disorder

Keywords

Panic disorder, cognitive behavior therapy, Internet

Brief summary

From the scarce literature it showed that computer/internet-aided cognitive behavior therapy (CBT) was superior to waitlist and placebo assignment across outcome measures, and the effects of computer/internet-aided CBT were equal to therapist-delivered treatment across anxiety disorders. The aim of this study is to evidence the effectiveness of internet-based relaxation with biofeedback treatment for panic disorder.

Detailed description

All participants had access to a computer with an internet connection and received the treatment via internet.

Interventions

BEHAVIORALBiofeedback

Patients with panic disorder practice muscle relaxation with temperature biofeedback monitor, and send the temperature data to server via internet every day. Therapist gives comments and suggestions on line. Patients also have to complete some self-rating scales on browser every day or every week.

BEHAVIORALMuscle Relaxation

Patients with panic disorder practice muscle relaxation via internet every day. Therapist gives comments and suggestions on line. Patients also have to complete some self-rating scales on browser every day or every week.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. The participant must fulfill DSM-IV criteria for panic disorder. 2. The participant must be between 20 and 60 years of age. 3. The participant must have the Panic Disorder Severity Scale(PDSS) score ≧8. 4. If the participant is taking prescribed drugs for panic disorder, a) the dosage have to be constant for 6 weeks before starting treatment, and b) the participant have to agree to keep the dosage constant for 2 months after starting treatment. 5. If the participant was already in therapy, the contact must have lasted at least 3 months and not be based on cognitive behavior therapy. 6. All participants have access to a computer with an Internet connection.

Exclusion criteria

1. The participant suffers from any other psychiatric disorder in immediate need of treatment. 2. The participant fulfills DSM-IV criteria for major depression. 3. The participant has epilepsy, kidney problems, strokes, organic brain syndrome, emphysema, heart disorders, or chronic hypertension. 4. The participant has alcoholism or substance dependence.

Design outcomes

Primary

Measure	Time frame
Score Change of The Panic Disorder Severity Scale(PDSS)	Baseline / Week 4/ Week 8/ Week12/ Week 16

Secondary

Measure	Time frame
Score Change of relaxation-rating	Baseline / Week 4/ Week 8/ Week 12/ Week 16

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026